logo

Exhibiting at VIV Asia 2025

3-47103
Bangkok
12 Mar - 14 Mar, 2025

Product Offerings

Products:

Veterinary Medicines: Injection Solutions, Suspension for Injection, Water-Soluble Powders, Sterile Powders for Injection

Aquatic Medicines: Specialized Treatments for Aquatic Animals

Nutritional Supplements: Liquid and Powder Forms

GOOVET Group Joint Stock Company is a prominent Vietnamese manufacturer specializing in veterinary pharmaceuticals and aquatic animal health products. Headquartered in Viet Tri, Phu Tho Province, Vietnam, GOOVET has established itself as a key player in the veterinary medicine sector, with a strong presence across domestic and international markets.

Founded with a mission to improve livestock and aquaculture health through innovation and quality, GOOVET integrates science-backed R&D, GMP-certified manufacturing processes, and stringent quality control systems to deliver reliable animal health solutions.

Core Business and Product Offerings

GOOVET operates across three primary verticals in animal health:

  • Veterinary Pharmaceuticals:

    • Injection Solutions: Broad-spectrum antibiotics, anti-inflammatory drugs, and specialized treatments
    • Suspension for Injection: Long-acting medications for livestock
    • Water-Soluble Powders: Easily administered treatment for poultry and swine
    • Sterile Powders for Injection: Fast-acting therapeutic agents for emergency and chronic conditions
  • Aquatic Animal Medicines:

    • Tailored products for disease prevention and treatment in shrimp, fish, and other aquaculture species
    • Specialized antibiotics, probiotics, and water conditioning solutions
  • Nutritional Supplements:

    • Formulated in both liquid and powder forms to enhance animal immunity, growth rate, and overall health
    • Includes prebiotics, enzymes, vitamins, and mineral mixes

The product range is developed in alignment with the regulatory requirements of the Ministry of Agriculture and Rural Development (MARD) in Vietnam and conforms to international veterinary pharmaceutical standards.

Specialization and Core USP

GOOVET's unique value proposition lies in its dual focus on livestock and aquatic animal health, serving two of the most critical sectors in Vietnam’s agricultural economy. The company maintains a vertically integrated model encompassing:

  • In-house R&D laboratories for pharmaceutical formulation
  • GMP-WHO certified production facilities
  • Nationwide distribution network reaching over 40 provinces
  • Strategic export partnerships with distributors in Southeast Asia and the Middle East

This enables GOOVET to offer tailored treatment solutions with guaranteed traceability and compliance, strengthening trust among veterinarians and farm operators.

Financial Performance

While GOOVET is a privately held company and does not publish audited financial statements, industry analysts in Vietnam’s animal health sector estimate that the company has grown its revenue consistently by 15–20% annually over the past five years. This growth is driven by:

  • Rising demand for high-quality veterinary drugs in Vietnam
  • Expansion of aquaculture farming zones
  • New product introductions and formulation updates

The company’s pricing and production efficiency have enabled it to remain competitive against both domestic and imported brands.

International Shipments and Export Data

Trade data suggests that GOOVET has developed a growing export profile. Platforms like Volza and TradData indicate shipments of veterinary pharmaceuticals and supplements to:

  • Cambodia
  • Laos
  • Myanmar
  • Bangladesh
  • United Arab Emirates

HS Code categories such as 3004.90 (medicaments consisting of mixed or unmixed products) appear prominently in shipment records, with increasing volume over the last 3 years. Export partnerships are often facilitated through trade fairs and B2B platforms endorsed by Vietnam’s Ministry of Industry and Trade.

Target Markets

GOOVET's core customer segments include:

  • Veterinary clinics and pharmacies
  • Livestock farms (swine, poultry, cattle)
  • Aquaculture farms (shrimp, catfish, tilapia)
  • Agricultural cooperatives and feed suppliers
  • Government-led animal health programs

The company’s domestic market strategy includes working closely with veterinary stations across provinces, while its export strategy is focused on emerging agricultural economies in Asia and the Middle East.

Capabilities

  • GMP-WHO Certified Manufacturing Plants
  • Fully Equipped R&D Labs for pharmaceutical innovation and stability testing
  • Quality Assurance Systems aligned with ISO standards
  • Logistics Network for cold chain and ambient shipping
  • Technical Advisory Teams to provide farm-level support

These integrated capabilities allow GOOVET to deliver cost-effective, timely, and quality-compliant veterinary solutions.

Certifications and Quality Compliance

GOOVET meets all required national and international compliance benchmarks for veterinary pharmaceutical manufacturing:

  • GMP-WHO Certification (Good Manufacturing Practice for Veterinary Medicines)
  • GLP (Good Laboratory Practices) for product testing
  • GSP (Good Storage Practice)
  • Product registration and licensing under Vietnam’s Department of Animal Health (DAH)

All products go through rigorous quality checks, batch traceability, and are labeled with safety and efficacy documentation.

Customer Testimonials

Feedback from long-standing veterinary practitioners and farm operators published on agricultural forums and GOOVET’s social media channels emphasizes:

  • Product reliability and visible health improvements in livestock
  • Responsive technical support
  • Trust in consistent supply and quality

Recognitions and Achievements

  • Named among the Top 10 Veterinary Medicine Brands in Vietnam by local trade publications
  • Regular participant in Vietnam Animal Husbandry Expo and regional veterinary conferences
  • Recognized by MARD for contributions to livestock and aquaculture health initiatives

GOOVET Group continues to invest in modernizing its production infrastructure and expanding its global outreach, reaffirming its position as a leader in Vietnam’s veterinary pharmaceutical industry.